Jentadueto
Manufacturing · Connecticut, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
900 Ridgebury Rd, Ridgefield, Connecticu...Website
www.jentadueto.comRevenue
$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Jentadueto
JENTADUETO combines two medicines that demonstrated improvements in blood sugar control: the DPP-4 inhibitor, linagliptin, and metformin. Linagliptin (5 mg, once-daily) is marketed in the U.S. as TRADJENTA. TRADJENTA has demonstrated significant reductions in A1C when used as monotherapy and in combination with metformin, sulfonylurea and pioglitazone. Metformin is a commonly used antihyperglycemic medication that improves glucose tolerance by lowering both basal and postprandial plasma glucose.Explore more
Popular SearchesJentaduetoSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Jentadueto your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Jentadueto
Product Launch: Get notified when Jentadueto launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Jentadueto, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Jentadueto had a recent Job posting/layoffs
Check out if Jentadueto is spiking on competitors!
Funding: Get notified immidiatlly once Jentadueto has new funding data
Check if Jentadueto has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Jentadueto recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Jentadueto
Compare insights from companies similar to Jentadueto, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Jentadueto is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Jentadueto is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Jentadueto.
Jentadueto Tech Stack
A closer look at the technologies used by Jentadueto
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Jentadueto
Sign Up For FreeTo access detailed company insights
JENTADUETO combines two medicines that demonstrated improvements in blood sugar control: the DPP-4 inhibitor, linagliptin, and metformin. Linagliptin (5 mg, once-daily) is marketed in the U.S. as TRADJENTA. TRADJENTA has demonstrated significant reductions in A1C when used as monotherapy and in combination with metformin, sulfonylurea and pioglitaz... Read More
